For one candidate drug of interest, the angiotensin-II-receptor blocker candesartan. 1st
For 1 candidate drug of interest, the angiotensin-II-receptor blocker candesartan. Initial, we assessed whether concomitant candesartan dosing merely altered the major pharmacokinetics of temozolomide . We located candesartan didn’t considerably…